國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 855504      Online Users : 1164
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Conference Papers/Meeting Abstract [1/2]
    Periodical Articles [4/4]

    Community Statistics


    Item counts issued in 3 years:5(83.33%)
    Items With Fulltext:5(83.33%)

    Download counts of the item
    Download times greater than 0:5(100.00%)
    Download times greater than 100:4(80.00%)
    Total Bitstream Download Counts:579(0.01%)

    Last Update: 2024-11-28 15:43

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-6 of 6. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DateTitleRelation
    2024-05-22 Predicting clinically significant prostate cancer using urine metabolomics via liquid chromatography mass spectrometry World Journal of Mens Health. 2024 May 22;42:Article number e59.
    2023-10-11 Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study Journal of Translational Medicine. 2023 Oct 11;21:Article number 714.
    2022-07-01 Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor PLoS ONE. 2022 Jul 1;17(7):Article number e0270803.
    2022-05 Matriptase-2/NR4A3 axis switches TGF-beta action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis Oncogene. 2022 May;41(20):2833-2845.
    2022-02 Aspalathus linearis suppresses AKT signaling, c-Myc, AR and survival of enzalutamide-resistant prostate cancer cells Cancer Science. 2022 Feb;113(S1):1338.
    2020-02 Crosstalk of post-translational modifications upon ERalpha activation Cancer Research. 2020 Feb;80(4, Suppl.):Meeting Abstract P6-05-13.

    Showing items 1-6 of 6. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback